VERTEX PHARMACEUTICALS INC / MA Pre-tax Income 2008-2026 | VRTX
Beta
What is VERTEX PHARMACEUTICALS INC / MA's current pre-tax income?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual pre-tax income for 2025 was $4.64B, a 1768.49% increase from 2024. VERTEX PHARMACEUTICALS INC / MA pre-tax income for the quarter ending March 31, 2026 was $1.25B.
What was VERTEX PHARMACEUTICALS INC / MA's pre-tax income in 2024?
VERTEX PHARMACEUTICALS INC / MA annual pre-tax income for 2024 was $248.5M, a 94.33% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's pre-tax income in 2023?
VERTEX PHARMACEUTICALS INC / MA annual pre-tax income for 2023 was $4.38B, a 3.48% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year pre-tax income CAGR?
VERTEX PHARMACEUTICALS INC / MA pre-tax income grew at a compound annual growth rate (CAGR) of 8.30% from FY2020 to FY2025, going from $3.12B to $4.64B over 5 years.
Pre-tax Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+8.3%
FY2020
$3.12B
→
FY2025
$4.64B
080910111213141516171819202122232425
5 years selected
Pre-tax Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $4.64B | +1768.5% | 10-K |
| FY2024 | $248.5M | -94.3% | 10-K |
| FY2023 | $4.38B | +3.5% | 10-K |
| FY2022 | $4.23B | +55.0% | 10-K |
| FY2021 | $2.73B | -12.4% | 10-K |
| FY2020 | $3.12B | +123.4% | 10-K |
| FY2019 | $1.39B | +132.4% | 10-K |
| FY2018 | $600.2M | +3925.9% | 10-K |
| FY2017 | $-15.7M | +76.7% | 10-K |
| FY2016 | $-67.4M | +87.9% | 10-K |
| FY2015 | $-557.8M | +24.1% | 10-K |
| FY2014 | $-734.9M | -17.4% | 10-K |
| FY2013 | $-626.0M | -2056.6% | 10-K |
| FY2012 | $32.0M | -47.1% | 10-K |
| FY2011 | $60.4M | +108.0% | 10-K |
| FY2010 | $-754.6M | -17.5% | 10-K |
| FY2009 | $-642.2M | -39.6% | 10-K |
| FY2008 | $-459.9M | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →